Pfizer CEO Albert Bourla collects $27.6M in 2025 pay following Metsera, MFN deals
Pfizer’s CEO, Albert Bourla, Ph.D., has yet to top the $33 million in compensation that he earned on the coattails of megablockbuster COVID-19 sales in 2022, but a $27.6 million pay package after a busy 2025 isn’t too shabby.
Bourla’s 2025 rewards are his second-largest since he took the helm at Pfizer in 2019, topping last year’s increase to $24.6 million.